News May 03, 2021 EPFL spin-off ONWARD raises $ 32 million for its spinal cord therapies ONWARD has raised $ 32 million to further develop and commercialize its ARC therapy stimulating the spinal cord to restore movement.
News Aug 25, 2020 Bloom Diagnostics raises capital for COVID-19 antibody tests The smart diagnosis system developed by Bloom Diagnostics is set to make COVID-19 antibody testing accessible to all. The test process takes just...
Actualités May 03, 2021 ONWARD, spin-off de l’EPFL, lève $ 32 millions pour ses thérapies de moelle épinière ONWARD a levé $ 32 millions pour poursuivre le développement et la commercialisation de sa thérapie ARC qui stimule la moelle épinière pour rétab...